Search Results 1051-1060 of 19064 for Enzyme

  1. Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction - Mayo Clinic

    Dabrafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. ... enzyme-inducing anticonvulsants for > 4 weeks; History ...

  2. Neuropathology and Microscopy Lab: Dennis W. Dickson - Mayo Clinic Research

    The latter are based on Western blotting and enzyme-linked immunoassays. The lab's research focuses on the interface between normal aging and dementia, as ...

  3. Overview - Neuropathology and Microscopy Lab: Dennis W. Dickson - Mayo Clinic Research

    The latter are based on Western blotting and enzyme-linked immunoassays. The lab's research focuses on the interface between normal aging and dementia, as ...

  4. Thoroughness is credited by Canadian for early Prostate Cancer Diagnosis - Mayo Clinic News Network

    Mayo Clinic Researchers Identify Enzyme Involved in Deadly Brain Tumors · Mayo Clinic Named to Fortune's “100 Best Companies to Work For” List. Related ...

  5. Focus Areas - Phospholipid Signaling in Embryonic Development and Human Diseases: Kun Ling - Mayo Clinic Research

    Mayo Clinic's Phospholipid Signaling in Embryonic Development and Human Diseases Lab led by Kun Ling, Ph.D., studies phosphoinositide species and enzymes in ...

  6. Testicular Cancer Clinical Trials - Mayo Clinic Research

    Dabrafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Retroperitoneal Lymph Node Dissection in Treating ...

  7. Carcinoma Of Unknown Primary Clinical Trials - Mayo Clinic Research

    Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This ...

  8. Mafenide (topical route) - Side effects & dosage - Mayo Clinic

    Glucose-6-phosphate dehydrogenase deficiency (lack of G6PD enzyme)—Use of mafenide in persons with this condition may result in hemolytic anemia. Kidney ...

  9. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough - Mayo Clinic

    ... enzyme immunoassay for specific IgE against at least one of the ... - Treatment with angiotensin-converting enzyme (ACE) inhibitor within 12 weeks prior to

  10. Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    About this study. RATIONALE: Aurora A kinase inhibitor MLN8237 and bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for ...